Best Monoamine Oxidase Inhibitor for Depressive Disorder — ranked (2026) · pharmaranks
Best Monoamine Oxidase Inhibitor for depressive disorder
2 Monoamine Oxidase Inhibitor drugs indicated for depressive disorder, ranked by our independent rating. The current highest-rated is emsam. Compare them with all treatments for depressive disorder or the full Monoamine Oxidase Inhibitor class. Not medical advice — always consult a professional.
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate
Top monoamine oxidase inhibitor for depressive disorder:1. Emsam · 2. Zelapar
Best-rated Monoamine Oxidase Inhibitor for depressive disorder, ranked by pharmaranks score
What is the best monoamine oxidase inhibitor for depressive disorder?
By our independent rating, emsam currently ranks highest among Monoamine Oxidase Inhibitor drugs used for depressive disorder. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Which monoamine oxidase inhibitor drugs treat depressive disorder?
pharmaranks lists 2 Monoamine Oxidase Inhibitor products indicated for depressive disorder, per FDA drug-label data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
zelapar
PrescriptionFDA-sourced
New
Selegiline hydrochloride is a levorotatory acetylenic derivative of phenethylamine.
monoamine oxidase inhibitormonoamine oxidase type b inhibitoralzheimer disease